
5HT1 causes vasoconstriction 
Therefore act to inhibit vasodilation related effects of migraine by

1. Reducing pain causing neuropeptide release eg Substance P CGRP
2. 
3. Preventing pain signal transmission along trigeminal nerve path ways


[[Y1KC3NzX - What would be a great combintation of SUMITRIPTAN and NAPROXEN for acute migraine]]






# reference 
5-HT1 agonists, particularly those that activate [5-HT1B/1D receptors](https://www.google.com/search?client=safari&hl=en-lk&authuser=1&cs=0&sca_esv=38b8b35f2fe0540c&q=5-HT1B%2F1D+receptors&sa=X&ved=2ahUKEwjbw-XIkfWOAxUee2wGHTpbKsEQxccNegQIAhAB&mstk=AUtExfAaYeyg5Qw3G_7VEveb_50KrOIhGK2YYUmvAI4PYYxYk2xzz8qvesqdXWf50eUmynFWHfWAKnc5rhWz4aW5WtVqAm4U77NA8QZ7K4Kfs0y5DmGdpAeazAznaeAWe5r_Nel3ZYlWXFS-IAWeDpZ3eReNQLNf5nbEfdI7H7nUbsvVB3euZK4k8UTHCQYQclkxTFUc&csui=3), help alleviate migraines by ==constricting dilated cranial blood vessels, inhibiting the release of pain-related neuropeptides, and reducing pain transmission within trigeminal pathways==. These actions help to normalize blood flow in the head and reduce the signals that contribute to migraine pain. 

Here's a more detailed explanation: 

1. [Vasoconstriction](https://www.google.com/search?client=safari&hl=en-lk&authuser=1&cs=0&sca_esv=38b8b35f2fe0540c&q=Vasoconstriction&sa=X&ved=2ahUKEwjbw-XIkfWOAxUee2wGHTpbKsEQxccNegQIDBAB&mstk=AUtExfAaYeyg5Qw3G_7VEveb_50KrOIhGK2YYUmvAI4PYYxYk2xzz8qvesqdXWf50eUmynFWHfWAKnc5rhWz4aW5WtVqAm4U77NA8QZ7K4Kfs0y5DmGdpAeazAznaeAWe5r_Nel3ZYlWXFS-IAWeDpZ3eReNQLNf5nbEfdI7H7nUbsvVB3euZK4k8UTHCQYQclkxTFUc&csui=3): Migraines are often associated with the dilation (widening) of blood vessels in the head, particularly those in the dura mater (the membrane surrounding the brain and spinal cord). 5-HT1B/1D agonists, like [sumatriptan](https://www.google.com/search?client=safari&hl=en-lk&authuser=1&cs=0&sca_esv=38b8b35f2fe0540c&q=sumatriptan&sa=X&ved=2ahUKEwjbw-XIkfWOAxUee2wGHTpbKsEQxccNegQIDxAB&mstk=AUtExfAaYeyg5Qw3G_7VEveb_50KrOIhGK2YYUmvAI4PYYxYk2xzz8qvesqdXWf50eUmynFWHfWAKnc5rhWz4aW5WtVqAm4U77NA8QZ7K4Kfs0y5DmGdpAeazAznaeAWe5r_Nel3ZYlWXFS-IAWeDpZ3eReNQLNf5nbEfdI7H7nUbsvVB3euZK4k8UTHCQYQclkxTFUc&csui=3), constrict these dilated vessels, reducing blood flow and helping to normalize the cranial circulation. 

2. Inhibition of Neuropeptide Release: Trigeminal nerves, which play a key role in migraine pain, release certain neuropeptides (like substance P and CGRP) that contribute to inflammation and pain. 5-HT1B/1D agonists can inhibit the release of these neuropeptides, reducing the inflammatory response and pain signals. 

3. Inhibition of Pain Transmission: 5-HT1B/1D agonists can also affect the transmission of pain signals within the trigeminal nerve pathways in the brainstem. By reducing the activity of these pathways, they help to decrease the perception of pain. 

4. [5-HT1F](https://www.google.com/search?client=safari&hl=en-lk&authuser=1&cs=0&sca_esv=38b8b35f2fe0540c&q=5-HT1F&sa=X&ved=2ahUKEwjbw-XIkfWOAxUee2wGHTpbKsEQxccNegQIJxAB&mstk=AUtExfAaYeyg5Qw3G_7VEveb_50KrOIhGK2YYUmvAI4PYYxYk2xzz8qvesqdXWf50eUmynFWHfWAKnc5rhWz4aW5WtVqAm4U77NA8QZ7K4Kfs0y5DmGdpAeazAznaeAWe5r_Nel3ZYlWXFS-IAWeDpZ3eReNQLNf5nbEfdI7H7nUbsvVB3euZK4k8UTHCQYQclkxTFUc&csui=3) Receptor Agonists: In addition to 5-HT1B/1D agonists, some newer migraine medications target the 5-HT1F receptor, such as [lasmiditan](https://www.google.com/search?client=safari&hl=en-lk&authuser=1&cs=0&sca_esv=38b8b35f2fe0540c&q=lasmiditan&sa=X&ved=2ahUKEwjbw-XIkfWOAxUee2wGHTpbKsEQxccNegQIJxAC&mstk=AUtExfAaYeyg5Qw3G_7VEveb_50KrOIhGK2YYUmvAI4PYYxYk2xzz8qvesqdXWf50eUmynFWHfWAKnc5rhWz4aW5WtVqAm4U77NA8QZ7K4Kfs0y5DmGdpAeazAznaeAWe5r_Nel3ZYlWXFS-IAWeDpZ3eReNQLNf5nbEfdI7H7nUbsvVB3euZK4k8UTHCQYQclkxTFUc&csui=3).While the exact mechanism is still being researched, it's believed that 5-HT1F agonists also help by reducing the release of neuropeptides and inhibiting pain signaling pathways. 

In essence, 5-HT1 agonists offer a multi-pronged approach to migraine relief by targeting both the vascular and neuronal aspects of the migraine process.